title: The risk of tachyarrhythmias in patients with moderate-to-severe chronic kidney disease receiving tiotropium bromide.
authors.affiliation: Chest Centre, University Hospital Aintree, Liverpool, UK; Athens Breath Centre, Athens, Greece; Respiratory Assembly, Hellenic Society for the Advancement of Biomedical Research, Athens, Greece. Electronic address: a.mathioudakis@nhs.net.
authors.forename: Alexander G
authors.initials: AG
authors.lastname: Mathioudakis
authors.affiliation: Respiratory Assembly, Hellenic Society for the Advancement of Biomedical Research, Athens, Greece; The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, USA.
authors.forename: Ioannis
authors.initials: I
authors.lastname: Mastoris
authors.affiliation: Athens Breath Centre, Athens, Greece; Respiratory Assembly, Hellenic Society for the Advancement of Biomedical Research, Athens, Greece.
authors.forename: Victoria
authors.initials: V
authors.lastname: Chatzimavridou-Grigoriadou
authors.affiliation: Athens Breath Centre, Athens, Greece.
authors.forename: Georgios A
authors.initials: GA
authors.lastname: Mathioudakis
mesh_terms: D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D013610:Tachycardia / Q000139:chemically induced* / Q000175:diagnosis*
chemical_list: D001993:Bronchodilator Agents
keywords: Arrhythmia; COPD; Human; Mortality; Therapeutics; Tiotropium